Sarcopenia is an important prognostic factor in patients with cervical cancer undergoing concurrent chemoradiotherapy
International Journal of Gynecological Cancer Jan 26, 2018
Kiyotoki T, et al. - The correlation between sarcopenia and prognostic factors in patients with cervical cancer (CC) undergoing concurrent chemoradiotherapy was determined. Sarcopenia (≥15.0% loss of iliopsoas muscle from baseline) was shown to be an important prognostic factor in these patients.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries